Contraceptives Drugs Market: Snapshot
Childbearing at an early age has become an issue of concern and to prevent the deaths caused due to this aspect, contraceptives are essential. Therefore, the growing demand for contraceptives drugs to experience fewer complications may bring great growth opportunities for the contraceptives drugs market through the forecast period of 2020-2030.
The growing population across the world due to unwanted pregnancies is soaring day-by-day. The need to tackle the rising number of unplanned pregnancies may serve as a prominent growth generator for the contraceptives drugs market between 2020 and 2030.
On the basis of type, the global contraceptives drugs market can be classified into topical contraceptives, contraceptive injectables, progestogen-only pills, oral contraceptives, combined oral contraceptive pills, and others. Based on the distribution channel, the contraceptives drugs market can be segmented into online pharmacy, retail pharmacy, hospitals and clinics, and others.
This report will offer ideal insights into the global contraceptives drugs market. The report covers diverse growth parameters such as competitive scenario, geographical perspective, and the emerging trends across the contraceptives drugs market. The report also provides a bird’s eye view on the COVID-19 impact and its effect on the contraceptives drugs market.
Request a sample to get extensive insights into the Contraceptives Drugs Market
Contraceptives Drugs Market: Industry Insights
The contraceptives drugs market can be categorized as highly fragmented due to the presence of numerous players vying to be among the top competitors. A considerable chunk of major players dominate the contraceptives drugs market and bring immense growth share. Research and development activities are also carried out on a large scale across various parameters to discover new insights. Furthermore, quick approvals from the regulatory authorities like the Food and Drug Administration (FDA) may benefit the growth rate of the contraceptives drugs market greatly.
In addition, mergers, acquisitions, partnerships, joint ventures, and collaborations help in strengthening the foothold of the players in the contraceptives drugs market, eventually aiding in increasing the growth rate of the contraceptives drugs market.,
Some well-established participants in the contraceptives drugs market are Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Bayer AG, Sanofi, and Pfizer Inc.
Contraceptives Drugs Market: Oral Contraceptives Inviting Extensive Growth
The emergence of oral pills as an easy way of contraception may serve as a great growth generator for the oral contraceptives segment. These pills are consumed by a considerable populace due to its ease of use. In addition, acts like the Affordable Care Act (ACA) enable the free distribution of oral pills to women who are covered under the act. Such acts trigger tremendous growth opportunities for the contraceptives drugs market.
Novel oral pill launches are also inviting great growth prospects for the contraceptives drugs market. For instance, Mayne Pharma completed licensing for its novel oral contraceptive pill known as NEXTSTELLIS and expects to launch the product soon after necessary FDA approvals.
Contraceptives Drugs Market: Novel Discoveries
New insights through research and development activities may bring expansive growth opportunities for the contraceptives drugs market. For instance, scientists recently developed the gelatin capsule, a contraceptive pill that has to be consumed only once a month. It will help in preventing unplanned pregnancies.
In another development, the FDA recently approved a contraceptive known as Phexxi. It is a non-hormonal vaginal gel that can be used for preventing pregnancy. The gel is a blend of lactic acid, potassium bitartrate, and citric acid. It keeps the vaginal pH levels in a range that’s inhospitable to sperm.
To understand how our report can bring difference to your business strategy, Ask for a brochure
Contraceptives Drugs Market: From Geographical Perspective
Densely populated countries like India and China may procure extensive demand for contraceptives drugs, eventually making Asia Pacific as one of the most important growth contributors across the forecast period. Initiatives related to awareness about family planning and avoiding unwanted pregnancies are being taken by the governments of various countries in Asia Pacific. This aspect may serve as a vital growth multiplier.
For instance, The Indian Government launched two new contraceptives named ‘Antara’, an injectable, and ‘Chayya’ a pill for free distribution among its citizens. The pills are available at medical colleges and hospitals across various states in India.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.